18th GCC Closed Forum: Compliance with FDA Biomarkers Guidance, Novel ELN/LIMS Platforms, Sample Reconciliation, Emerging Technologies, Improvements in ELISpot, Post-extraction Sample Stability, LBA Singlicate, Regulatory Inspections, Chicken anti-Human IgG, Cross-validation Harmonization.

Karnik S, Zimmer J, Gutekunst M, Gorityala S, Goodman J, Jerks E, Litwin V, Tang X, Leskovar A, Tary-Lehmann M, Lowes S, Lavelle A, Yuan M, Liu A, O'Brien K, Dong K, Sales K, Reuschel S, Keyhani A, Johnson D, Odell M, Abdeen SJ, Hays A, Beyerlein D, Johnson M, Yu M, Cotton S, Joyce P, Fang WWT, Garofolo W, Nadarajah S, Spytko A, Dufield D, Rutherford L, Pankratz T, Xu A, Sikkema D, Hyer E, Iles T, Bonner E, Dimarco C, Hristopoulos G, Patterson K, Nash B, Bretton V, Rocha A, Satterwhite C, Yamashita J, McNally J, Fang X, Fan L